Meprobamate: still approved in France: labelling change. No role for meprobamate, in any indication. Safer options are available

Prescrire Int. 2008 Jun;17(95):108.
No abstract available

MeSH terms

  • Anxiety / drug therapy*
  • Drug Approval
  • Drug Labeling
  • Drug Therapy, Combination
  • France
  • Humans
  • Meprobamate / administration & dosage
  • Meprobamate / adverse effects
  • Meprobamate / therapeutic use*

Substances

  • Meprobamate